Unprecedented demand for metabolic health therapeutics has exposed critical bottlenecks in specialized sterile injectable manufacturing. Leading drugmakers are pouring billions into dedicated production facilities to mitigate chronic global shortfalls.
CapEx Allocation for Sterile Manufacturing
Filling and finishing complex peptide formulations requires advanced cold-chain infrastructure and precise volumetric controls. Independent CDMOs are reallocating capital from legacy small-molecule lines to expand high-speed automated syringe filling capacity.